AQR Capital Management
TMDX icon

AQR Capital Management’s Transmedics TMDX Stock Holding History

AQR Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$773K Buy
7,779
+2,971
+62% +$388K ﹤0.01% 2902
2025
Q4 		$585K Sell
4,808
-3,789
-44% -$475K ﹤0.01% 2829
2025
Q3 		$965K Buy
8,597
+3,629
+73% +$425K ﹤0.01% 2459
2025
Q2 		$666K Buy
+4,968
New +$545K ﹤0.01% 2449
2025
Q1 		– Sell
-4,232
Closed -$264K – 3199
2024
Q4 		$264K Sell
4,232
-4,937
-54% -$460K ﹤0.01% 2561
2024
Q3 		$1.44M Buy
9,169
+6,154
+204% +$948K ﹤0.01% 1660
2024
Q2 		$454K Sell
3,015
-353
-10% -$42.3K ﹤0.01% 2087
2024
Q1 		$249K Sell
3,368
-2,935
-47% -$242K ﹤0.01% 2196
2023
Q4 		$497K Buy
6,303
+223
+4% +$13.5K ﹤0.01% 1882
2023
Q3 		$333K Sell
6,080
-1,369
-18% -$98.5K ﹤0.01% 1984
2023
Q2 		$626K Buy
7,449
+882
+13% +$67.5K ﹤0.01% 1726
2023
Q1 		$497K Buy
6,567
+1,197
+22% +$82.8K ﹤0.01% 1778
2022
Q4 		$331K Sell
5,370
-957
-15% -$50.9K ﹤0.01% 1944
2022
Q3 		$264K Buy
+6,327
New +$275K ﹤0.01% 1979

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management's TMDX Position: Q1 2026 in Review

AQR Capital Management increased its Transmedics (TMDX) stake by 62% in Q1 2026, buying an estimated $388K and bringing the position to 7,779 shares worth $773K. The position accounts for ﹤0.01% of the portfolio, ranked #2902.

AQR Capital Management first reported a position in TMDX in Q3 2022 and has held it in 14 quarters since. The position peaked at $1.44M in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • AQR Capital Management held 7,779 shares of Transmedics worth $773K as of Q1 2026.
  • AQR Capital Management bought 2,971 Transmedics shares in Q1 2026, an estimated $388K.
  • Transmedics made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #2902 holding.
  • AQR Capital Management first reported a position in Transmedics in Q3 2022 and has held it in 14 quarters since.
  • AQR Capital Management's Transmedics position peaked at $1.44M in Q3 2024.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.